EPIGENESIS.COM Trademark

Trademark Overview


On Wednesday, August 23, 2000, a trademark application was filed for EPIGENESIS.COM with the United States Patent and Trademark Office. The USPTO has given the EPIGENESIS.COM trademark a serial number of 76122100. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, July 14, 2006. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The EPIGENESIS.COM trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic and therapeutic preparations and devices, for administering same, sold filled, with, diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such a...
epigenesis.com

General Information


Serial Number76122100
Word MarkEPIGENESIS.COM
Filing DateWednesday, August 23, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, July 14, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 15, 2003

Trademark Statements


Goods and ServicesMedical diagnostic and therapeutic preparations and devices, for administering same, sold filled, with, diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostrate included
Pseudo MarkEPIGENESIS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 21, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIGENESIS PHARMACEUTICALS LLC
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRANBURY, NJ 08512

Party NameEPIGENESIS PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRANBURY, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Wednesday, September 13, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, September 13, 2006ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 29, 2005EXTENSION 5 GRANTED
Thursday, December 29, 2005EXTENSION 5 FILED
Thursday, December 29, 2005TEAS EXTENSION RECEIVED
Friday, July 1, 2005EXTENSION 4 GRANTED
Friday, July 1, 2005EXTENSION 4 FILED
Friday, July 1, 2005TEAS EXTENSION RECEIVED
Monday, January 10, 2005EXTENSION 3 GRANTED
Thursday, December 23, 2004EXTENSION 3 FILED
Thursday, December 23, 2004TEAS EXTENSION RECEIVED
Thursday, July 29, 2004EXTENSION 2 GRANTED
Tuesday, July 6, 2004EXTENSION 2 FILED
Monday, July 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 16, 2004PAPER RECEIVED
Tuesday, July 13, 2004CASE FILE IN TICRS
Tuesday, July 6, 2004TEAS EXTENSION RECEIVED
Thursday, January 29, 2004EXTENSION 1 GRANTED
Wednesday, January 7, 2004EXTENSION 1 FILED
Wednesday, January 7, 2004TEAS EXTENSION RECEIVED
Tuesday, July 8, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 15, 2003PUBLISHED FOR OPPOSITION
Wednesday, March 26, 2003NOTICE OF PUBLICATION
Thursday, July 18, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 5, 2002ASSIGNED TO EXAMINER
Tuesday, March 5, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 29, 2001FINAL REFUSAL MAILED
Friday, August 17, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2001NON-FINAL ACTION MAILED
Wednesday, January 24, 2001ASSIGNED TO EXAMINER
Tuesday, January 23, 2001ASSIGNED TO EXAMINER